BDBM50333262 4-(2-(4-chloro-3-fluorophenylamino)-2-oxoacetamido)-1,2,2,6,6-pentamethylpiperidine 1-oxide::CHEMBL1645130

SMILES: CC1(C)CC(CC(C)(C)[N+]1(C)[O-])NC(=O)C(=O)Nc1ccc(Cl)c(F)c1

InChI Key: InChIKey=DNJQCBFBABSUGD-UHFFFAOYSA-N

Data: 1 IC50  1 Kd

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50333262   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Envelope glycoprotein gp160 (Human immunodeficiency virus type 1 group M subtyp...)	BDBM50333262 (4-(2-(4-chloro-3-fluorophenylamino)-2-oxoacetamido...) Show SMILES CC1(C)CC(CC(C)(C)[N+]1(C)[O-])NC(=O)C(=O)Nc1ccc(Cl)c(F)c1 |(20.21,-44.3,;18.73,-44.71,;19.49,-46.04,;17.41,-45.48,;16.08,-44.71,;16.06,-43.17,;17.4,-42.4,;16.62,-41.06,;18.16,-41.06,;18.74,-43.17,;19.49,-41.83,;20.27,-43.17,;14.75,-45.49,;13.41,-44.72,;13.4,-43.18,;12.08,-45.5,;12.09,-47.04,;10.74,-44.73,;9.41,-45.51,;8.08,-44.74,;6.75,-45.52,;6.75,-47.06,;5.41,-47.83,;8.08,-47.83,;8.08,-49.37,;9.42,-47.06,)| Show InChI InChI=1S/C18H25ClFN3O3/c1-17(2)9-12(10-18(3,4)23(17,5)26)22-16(25)15(24)21-11-6-7-13(19)14(20)8-11/h6-8,12H,9-10H2,1-5H3,(H,21,24)(H,22,25)	PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	1.30E+3	n/a	n/a	n/a	n/a	n/a
Bryn Mawr College Curated by ChEMBL					Assay Description Binding affinity to HIV1 YU2 gp120 by isothermal titration calorimetry assay				Bioorg Med Chem 19: 91-101 (2011) Article DOI: 10.1016/j.bmc.2010.11.049 BindingDB Entry DOI: 10.7270/Q25H7GHH
					More data for this Ligand-Target Pair
Envelope glycoprotein gp160 (Human immunodeficiency virus type 1 group M subtyp...)	BDBM50333262 (4-(2-(4-chloro-3-fluorophenylamino)-2-oxoacetamido...) Show SMILES CC1(C)CC(CC(C)(C)[N+]1(C)[O-])NC(=O)C(=O)Nc1ccc(Cl)c(F)c1 |(20.21,-44.3,;18.73,-44.71,;19.49,-46.04,;17.41,-45.48,;16.08,-44.71,;16.06,-43.17,;17.4,-42.4,;16.62,-41.06,;18.16,-41.06,;18.74,-43.17,;19.49,-41.83,;20.27,-43.17,;14.75,-45.49,;13.41,-44.72,;13.4,-43.18,;12.08,-45.5,;12.09,-47.04,;10.74,-44.73,;9.41,-45.51,;8.08,-44.74,;6.75,-45.52,;6.75,-47.06,;5.41,-47.83,;8.08,-47.83,;8.08,-49.37,;9.42,-47.06,)| Show InChI InChI=1S/C18H25ClFN3O3/c1-17(2)9-12(10-18(3,4)23(17,5)26)22-16(25)15(24)21-11-6-7-13(19)14(20)8-11/h6-8,12H,9-10H2,1-5H3,(H,21,24)(H,22,25)	PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	>1.00E+5	n/a	n/a	n/a	n/a	n/a	n/a
Bryn Mawr College Curated by ChEMBL					Assay Description Inhibition of HIV1 YU2 gp120 binding to CD4 expressing Cf2Th-CD4/CCR5 cells assessed as inhibition of viral infection after 48 hrs				Bioorg Med Chem 19: 91-101 (2011) Article DOI: 10.1016/j.bmc.2010.11.049 BindingDB Entry DOI: 10.7270/Q25H7GHH
					More data for this Ligand-Target Pair